Scandion Oncology A/S signs agreement with Sedermera Fondkommission AB regarding an Initial Public Offering at Spotlight Stock Market.

Scandion Oncology A/S hereby announces that an agreement has been signed with Sedermera Fondkommission in order to finalize plans for an Initial Public Offering (IPO) at Spotlight Stock Market, Stockholm, in the fall of 2018.

The full Press Release can be viewed here

Co-funded by the Horizon 2020 programme of the European Union
Co-funded by the COSME programme of the European Union